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Introduction
Familial hypercholesterolemia (FH) is an inherited autosomal disease, which is caused by a mutation in the LDL receptor gene. 1 The incidence of the homozygous form of FH is 1:1 000 000, whereas the heterozygous form affects 1:500 individuals. 1 Characteristic symptoms of homozygous FH include severe hypercholesterolemia, xanthomas, arcus corneae and premature coronary heart disease. 1 Various treatment methods, such as diet, bile acid binding resins, 2 statins, 3 ileal bypass 4, 5 and portocaval anastomosis 6 have been used with little success. Currently, the only effective treatments for homozygous FH are liver transplantation, 7 LDL apheresis 8 and plasmapheresis. 9 However, these treatments are laborious 8 and in the case of liver transplantation contain risks with both operation and tissue rejection. Liver gene therapy has become a promising new alternative for the treatment of LDL receptor deficiency and other inherited liver diseases. Since liver transplantation in homozygous FH has been shown to correct hyperlipidemia, 1, 10 it is likely that even a partial restoration of LDLreceptor activity in the liver should be sufficient to cause a beneficial treatment effect. Watanabe heritable hyperlipidemic (WHHL) rabbit can be used as an animal model for FH gene therapy, since the rabbits have a 12 nucleotide deletion in their LDL receptor gene 11 leading to a similar dyslipidemia as in human FH.
Ex vivo and in vivo approaches have been used in the liver-directed gene therapy. The ex vivo method was utilized in the first human LDL receptor gene therapy trial. 12 However, low gene transfer efficiency and laborious ex vivo techniques seem to constitute major obstacles for ex vivo liver gene therapy. Direct in vivo gene transfer is an alternative approach for ex vivo liver gene therapy. It can be performed by injection of the gene transfer vectors into the portal vein 13 or splenic vein. 14 Since retroviral vectors require proliferation of the target cells, partial liver resection up to 70% of the liver mass has been used to stimulate hepatocyte proliferation. In spite of liver resection, gene transfer efficiency in hepatocytes has generally been low. Improved gene transfer efficiency has been achieved by using high titer retroviruses 15 or by simultaneous administration of growth factors 16 or using temporary blockade of hepatic circulation. 17, 18 Also, triiodothyronine, 19 urokinase 20 and toxic substances such as carbon tetrachloride 21, 22 have been used to stimulate hepatocyte proliferation.
In order to minimize the need for liver resection and thus reduce the physical stress and risks of an extensive liver operation we now introduce an alternative method for the induction of hepatocyte proliferation by transient thymidine kinase gene transfer and ganciclovir treatment. Herpes simplex virus thymidine kinase is widely used in clinical trials for cancers. 23 It converts a nontoxic nucleoside analog ganciclovir into a toxic phosphorylated derivative that acts as a chain terminator of DNA synthesis and an inhibitor of DNA polymerase, selectively killing or damaging dividing cells. 24 To give a further stimulus for hepatocyte proliferation we used the same principle and injected thymidine kinase expression plasmid-liposome complex to the portal vein followed by ganciclovir treatment and repeated retrovirus injections via a portal catheter. It was found that temporary thymidine kinase expression in conjunction with partial liver resection increased hepatocyte proliferation rate and efficacy of LDL receptor gene transfer to WHHL rabbit liver.
Results
Liver gene transfer was performed after a limited (approximately 10%) liver resection and cathetrization of portal vein as described in Figure 1 . Since retroviruses can only deliver genes to proliferating cells, we determined hepatocyte proliferation indexes in the transduced livers 72 h after the operation (Figure 2 ). The basal level of proliferation in intact liver was 0.12% (±0.046%). Thymidine kinase-ganciclovir treatment without resection increased the index by six-fold up to 0.74% (±0.36%). Surgical resection increased the index by 7.5-fold, up to 0.91% (±0.34%). When combined, the two treatments resulted in 1.35% (±0.82%) proliferation index (ie an 11-fold increase from the basal level). Resection seems to stimulate hepatocyte proliferation preferentially in the resection lobe whereas in the group receiving the combined therapy cell proliferation also tended to be stimulated in the non-resection lobe (data not shown).
To analyze the distribution of injected material in the liver we first used 20% ink-saline injection in the portal vein. One hour after injection, ink particles were present around the periportal areas in all liver samples (Figure 3a) . In situ PCR of the transfected WHHL rabbit livers showed the presence of the transgene 6 days after the gene transfer and thymidine kinase and ganciclovir treatments. The amplified gene was found in the periportal areas similar to the distribution of carbon particles after intraportal ink injection (Figure 3b ). Transgene mRNA was detected in the transduced livers using RT-PCR 6 days after the gene transfer ( Figure 4 ) whereas no mRNA was detected in the livers after the 52-week follow-up period although the presence of the provirus could be demonstrated by genomic PCR (data not shown).
Gene transfer efficiency in resected livers that were not treated with thymidine kinase and ganciclovir was low with lacZ-containing pLZRNL retroviruses. One week after the gene transfer only a few positive blue-colored cells were seen with gene transfer efficiency of Ͻ0.01 positive cells/mm 2 (data not shown). Under these conditions LDL receptor gene transfer to WHHL rabbit liver did not lead to any changes in plasma cholesterol or triglyceride levels ( Figure 5 ). After 6 weeks follow-up animals that received LDL receptor gene transfer together with the thymidine kinase-ganciclovir treatment alone or partial liver resection alone showed no clinical effects on plasma lipid values ( Figure 5 ). (data not shown). In the case of LDL receptor gene transfer combined with the partial liver resection and thymidine kinase-ganciclovir treatment total plasma cholesterol level showed a maximal decline of 35% 8 weeks after the gene transfer ( Figure 5 ). The decline in total cholesterol level was significant (P Ͻ 0.05) as compared with the control rabbits treated with the combination of similar partial liver resection and thymidine kinase-ganciclovir treatment. A 50% decline was also observed in plasma triglyceride levels ( Figure 5 ) but the difference was not statistically significant. At the end of the follow-up period the decrease in total cholesterol level was 20% ( Figure 5 ). Control rabbits remained within the age-adjusted limits of the WHHL rabbit colony, which showed a typical steady decline of the total cholesterol and triglyceride values with age ( Figure 5 ). Alkaline phosphatase showed twofold and 4.5-fold elevations in LDL receptor transfected and control rabbits, respectively, which returned to baseline in 6 months ( Figure 6 ). Other parameters did not show any differences ( Figure 6 ). No helper viruses were detected in the plasma of the treated animals. 25 
Discussion
Earlier studies on WHHL rabbit LDL receptor gene therapy have been conducted using ex vivo approaches with retroviruses (25-40% cholesterol lowering for 4.5 months), in vivo approaches with DNA-protein complexes (25-30% transient cholesterol lowering for 2 weeks), and adenoviruses (56% transient cholesterol lowering at 7 days). [26] [27] [28] The first results of human gene therapy for the treatment of FH have also been reported. 12, 29 Human studies were carried out using the ex vivo gene transfer method, which is laborious and may not be applicable for widespread clinical use. The purpose of this study was to establish a method for direct in vivo gene transfer and to increase the clinical efficiency of the gene transfer by improving surgical methods and using additional biochemical stimulus for hepatocyte proliferation. An advantage of this method is the requirement for only a limited (approximately 10%) liver resection which should minimize the risks related to an extensive liver operation. However, a limited resection with thymidine kinase and ganciclovir treatment is needed for maximal gene transfer effect and probably cannot be replaced by thymidine kinase and ganciclovir treatment alone ( Figure 5) .
In a resting state less than 0.2% of hepatocytes are in a replication cycle ( Figure 3 ). As retrovirus can only infect proliferating cells, hepatocyte proliferation needs to be stimulated. This can be done by various methods. The most widely used stimulus is partial liver resection, where up to 70% of the total liver mass has been removed. In several weeks time liver gains its original weight. Carbon tetrachloride has also been used for the stimulation of hepatocyte proliferation. 21, 22, 30, 31 However, extensive surgical resection constitutes a considerable risk to the patient and carbon tetrachloride can cause uncontrollable liver damage. Various growth factors can also be used to stimulate liver proliferation at the time of gene transfer but side-effects of potent growth factors may limit their clinical use. 16 In the present study, gene transfer combined with liver resection alone did not cause any measurable effects on the plasma cholesterol or triglyceride levels. The most likely reasons for the failure to achieve any treatment effect were the low titer of retroviruses and the low proliferation rate of hepatocytes. We next tested retrovirusmediated LDL receptor gene transfer to the liver in combination with thymidine kinase and ganciclovir treatment and a limited liver resection. It was found that surgical resection combined with the thymidine kinase and ganciclovir increased the hepatocyte proliferation index 11-fold. With the combined therapy a 35% lowering in plasma cholesterol level was observed. A 20% decrease was still present after 52 weeks follow-up period. Plasma triglyceride levels showed a 50% decrease. Thus, our results indicate that direct intraportal in vivo gene transfer in combination with the limited surgical resection and 
Animals treated without thymidine kinase and ganciclovir received two injections of retroviruses 24 and 48 h after the operation. Control animals received only thymidine kinase expression plasmid-liposome complexes and ganciclovir with a partial liver resection. Solid lines (-) indicate trend lines. Dashed lines (---) ±s.d. (`) indicate the values of age-matched control WHHL rabbit population (n = 23). It is noteworthy that in WHHL rabbits both total cholesterol and triglyceride values show a gradual decline with age.
thymidine kinase-ganciclovir treatment can be used to improve the results of liver-directed gene therapy.
As far as the biosafety of the current method is concerned, the acute toxicity of the injected thymidine kinase plasmid could cause some problems since most of the toxicity would probably result from the bystander effect. 24 Adenovirus-mediated thymidine kinase gene 46 
Figure 6 Absolute values of aspartyl aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP) and lactate dehydrogenase (LDH) in control WHHL rabbits (᭹) and in WHHL rabbits after retrovirus-mediated LDL receptor gene transfer (pLDRNL; titer approximately 1 × 10 5 p.f.u./ml) after resection and thymidine kinase-ganciclovir treatment (ᮀ). Reference values for enzyme measurements (±s.d.) () are based on our WHHL rabbit colony.

Gene transfer was carried out as indicated in the legend for Figure 5. Control animals received only thymidine kinase expression plasmid-liposome complexes and ganciclovir with a partial liver resection.
transfer has also been reported to cause toxicity in mouse and rat liver. 32, 33 However, in this study during the 1 year follow-up there were no signs of adverse effects or irreversible alteration of liver function, which might be due to a less efficient, transient gene transfer by plasmid-liposomes in the absence of adenoviral components. Thus, it can be concluded that gene transfer together with the thymidine kinase and ganciclovir treatment was well-tolerated and, apart from the transient increase in alkaline phosphatase levels, no major changes were seen in the liver enzyme levels. Previously, adenoviruses expressing ␤-galactosidase under different promoters did not cause any significant changes in liver function tests after intraportal infusion. 28 The elevation in alkaline phosphatase level, which returned to the basal level within 4-6 months, may be due to a transient intrahepatic cholestasis. The increase did not have any correlation with the change in the plasma total cholesterol levels (data not shown). It also occurred in both the treatment and the control groups, which implies that it is not connected to LDL receptor gene transfer per se. However, it is possible that increased influx of cholesterol to the liver through the transfected LDL receptor could cause alterations in bile acid metabolism and liver function tests. A decrease in triglyceride levels probably reflects an improved uptake of VLDL remnants and intermediate density lipoproteins by the liver.
Our results suggest that long-lasting physiological effects can be achieved with direct retrovirus-mediated in vivo liver gene transfer. Even though the decline in cholesterol levels was modest, it was achieved using low titer MMLV retroviruses. In the future, further improvements in the treatment effect could be obtained by optimizing in vivo transfection conditions and by using high titer pseudotyped retroviruses, lentiviruses or adenoassociated viruses. [34] [35] [36] It is concluded that direct in vivo gene transfer may become a feasible alternative for the treatment of FH and other liver diseases. However, further developments in gene transfer vectors and transfection conditions are needed before the full potential of gene therapy can be explored. 
Materials and methods
Retroviruses
Moloney murine leukemia virus (MoMLV)-derived retroviruses containing rabbit LDL receptor cDNA 38 (pLDRNL) and lacZ cDNA 39 (pLZRNL) were used for the studies. The expression of LDL receptor is driven by 5′ LTR. Replication-deficient pLDRNL and pLZRNL amphotrophic retroviruses were packaged in PA317 cells and used at a titer of approximately 1 × 10 5 c.f.u./ml. Before use, retroviral preparations were checked for the absence of any bacteriological contaminants, lipopolysaccharide or helper viruses. 25 For a single dose, 2000 l of virus was mixed with 156 l of polybrene (800 g/l) and diluted to 5000 l with Ringer's solution.
Animals
A total of 29 (20 male, nine female) homozygous LDLreceptor-deficient WHHL rabbits (aged 3-8.5 months, weight 2014-2890 g) were obtained from the National Experimental Animal Center (University of Kuopio). The first group (n = 5) of animals received LDL-receptor cDNA in amphotrophic pLDRNL retroviruses with surgical liver resection, the second group (n = 3) of animals received LDL-receptor cDNA in amphotrophic pLDRNL retroviruses and were treated with thymidine kinase plasmid-liposome complexes-ganciclovir, and the third group (n = 5) of animals received LDL-receptor cDNA in amphotrophic pLDRNL retroviruses and were treated with both surgical resection and thymidine kinase plasmid-liposome complexes-ganciclovir to further induce hepatocyte proliferation. Control animals (n = 3) were only treated with surgical resection and thymidine kinase plasmid-liposomes-ganciclovir to serve as controls. In addition, 11 WHHL rabbits were used for BrdU and two WHHL rabbits for PCR studies. One New Zealand White (NZW) rabbit received 5 ml 20% ink-saline injection in the portal vein to determine the spread of the carbon particles in the liver. All animal studies were approved by the Ethical Committee of the University of Kuopio and the Finnish National Board for Gene Technology.
Surgical procedure and gene transfer
The animals were weighed, anesthetized with phentanylfluanizone 0.25 ml/kg s.c. (Hypnorm; Janssen Pharmaseutica, Beerse, Belgium) and midazolam 2 mg/kg i.m. (Dormicum; Roche, Basel, Switzerland). Cefuroxim 50 mg/kg (Zinacef; Glaxo, Middlesex, UK) was given i.m. for infection prophylaxis. A partial liver resection of two segments (approximately 10% of liver mass) was performed through laparotomy to stimulate the hepatocyte proliferation. Simultaneously, a 22G intrathecal catheter (Vygon, Ecouen, France) was placed in the portal vein under microscopic control (Figure 1 ) and the incision was carefully sutured to avoid bleeding. An injection plug (Ohmeda, Erlangen, Germany) was installed in the subcutaneous space and heparinized with 250 IU Heparin (Leiras, Turku, Finland) to permit subsequent injections to the portal vein without a re-operation.
Thymidine kinase expression plasmid-liposome complexes were given to animals intraportally via the catheter. Ganciclovir (Cymevene; Roche, Basel, Switzerland) was then given intraportally (25 mg/kg) at 0, 12 and 24 h after the operation. Thereafter, a retrovirus-mediated gene transfer was performed at 24, 48 and 72 h after the operation via the catheter. In other animals gene transfer was done similarly at 24, 48 and 72 h after the operation. Analysis of blood samples During 52 weeks follow-up aspartyl aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), c-reactive protein (CRP), lactate dehydrogenase (LDH) and lipid levels (total cholesterol (CHOL), high density lipoproteins (HDL), triglycerides (TG)) were monitored from fasting plasma samples using routine clinical chemistry assays at Kuopio University Hospital laboratory. Plasma total cholesterol, HDL cholesterol, triglyceride, liver enzyme values, CRP and LDH were measured by autoanalyzer (Specific; Kone Instruments, Espoo, Finland and Celtac Auto MEK-8118K; Nihon Kohden, Tokyo, Japan). The absence of helper viruses in plasma 7 days after the last gene transfer was determined using a bioassay on 209 F cells. 25 Histology and analysis of proliferation index After the 52 weeks follow-up time four animals were killed by barbiturate overdose. The remaining animals were kept for long-term follow-up. Tissue samples from the liver were excised for in situ hybridization and immunocytochemistry. 40 Samples from the liver (resection lobe), left lung and spleen were removed for RT-PCR analysis. 41 To obtain liver biopsies shortly after the operation two animals were reoperated on day 7.
Tissue specimens for paraffin sections were kept in 4% paraformaldehyde/phosphate-buffered saline (pH 7.4) for 4 h, immersed overnight in 15% sucrose/PBS (pH 7.4) and dehydrated for paraffin embedding. 40 Thick sections of 7 m were cut from the blocks and stored in a freezer at −20°C until analyzed. After perfusion fixation specimens for frozen sections were kept in 15% sucrose/PBS (pH 7.4) solution overnight and embedded in OCT compound (Miles, Elkhart, IN, USA). Cryostat sections of 7 m were cut and stored in a freezer at −70°C temperature until analyzed.
␤-Galactosidase activity was analyzed in unfixed liver sections by X-gal staining for 6 h. 25 After staining the sections were counterstained with Mayer's stain. Gene transfer efficiency was calculated as the number of ␤-galactosidase-containing hepatocytes/mm 2 in 10 randomly selected sections. 16 In one NZW rabbit, 5 ml volume of 20% ink in saline was injected into the portal vein catheter to visualize the spread of the fluid in different parts of the liver. One hour later the animal was killed and the liver was excised and processed for paraffin and frozen sections and counterstained with hematoxylin.
To compare hepatocyte proliferation activity at 72 h after liver resection three WHHL rabbits had liver resection with thymidine kinase-ganciclovir treatment and lacZ retrovirus gene transfer (RES-TK group). Three rabbits had only liver resection with lacZ gene transfer (RES group), three animals were only treated with thymidine kinase and ganciclovir with lacZ gene transfer (TK group) and two served as unoperated controls (C group). Rabbits were injected in the marginal ear vein with 15 mg/kg body weight of 5-bromo 5-iododeoxyuridine (BrdU) (Sigma Immunochemicals) 3 h before they were killed. The liver samples were then fixed overnight in 70% ethanol and embedded in paraffin. Serial sections were ana-lyzed for the proliferation index using a mouse monoclonal anti-BrdU antibody (clone Bu20A, Dako, Glostrup, Denmark), followed by FITC-labeled secondary antibody (Dako). 42 After the incubation, the slides were counterstained with hematoxylin to visualize the nuclei. Five ×100 fields were randomly selected for the counting of the BrdU-positive nucleae per total number of nuclei. Determination of the proliferation index was done by two independent observers without knowledge of the origin of the treatment groups. The interobserver correlation (TP, ML) was 0.98. Mean ± s.d. of the single observer (TP) results is reported.
Micrographs
Micrographs were taken by digital camera (SenSys KAF1400-G2; Photometrics, Tucson, AZ, USA), processed with digital image processing software (Image-Pro Plus; Media Cybernetics, Silver Spring, MD, USA) and printed using a sublimation printer (Kodak DS 8650; EastmanKodak, Rochester, NY, USA).
RT-PCR analysis
The presence and expression of the transgene was analyzed using RT-PCR and genomic PCR. 43 Total RNA was isolated by TRIzol reagent (LifeTechnologies, Rockville, MD, USA) from liver samples collected 6 days after the LDL receptor gene transfer or from the control rabbits subjected to thymidine kinase gene transfer and ganciclovir treatment. Two micrograms of DNAse-treated total RNA were reverse transcribed to first-strand cDNA using MoMLV reverse transcriptase (MBI Fermentas, Amherst, NY, USA) after random hexamer priming. All of the cDNA synthesis products were verified to be free of genomic DNA contamination by PCR. Primer sequences for the amplification of the transfected LDL receptor were as follows: upper primer was derived from the LDL receptor, 5′-ctgggggtcttccttctatgg-3′, the lower primer from the retrovirus vector RSV 5′-gtgctttttctctccttg-3′. Negative controls for cDNA synthesis (without RNA) and PCR (reaction without cDNA or primers) were included in every assay. 44 Thirty-five cycles of PCR were performed and the cycle parameters were 45 s at 95°C, 60 s at 56°C and 60 s at 72°C, except for the last cycle (7 min).
In situ PCR analysis
In situ PCR analysis 45 was performed 6 days after the gene transfer on liver samples obtained by laparotomy from WHHL rabbits that had also received thymidine kinase plasmid-liposomes and ganciclovir treatment and corresponding control animals. Paraffin-embedded sections were pretreated with proteinase K-RNAseA and the amplification was carried out with Dynazyme DNA polymerase (Finnzymes, Espoo, Finland) using the following program: first denaturation step at 95°C for 8 min, followed by 34 cycles with 30 s at 95°C, 45 s at 58°C and 45 s at 72°C. 45 Amplification primers were from the retroviral packaging signal (5′-ctgtccgattgtctagtgt-3′) and from the lacZ gene (5′-ctcttcgctattacgcca-3′) or the LDL-receptor gene (5′-acccacttgtaggagatgca3′). Detection after the amplification was carried out using in situ hybridization with DIG-labeled probes (Boehringer Mannheim, Mannheim, Germany) which recognize the middle portion of the amplified fragments. 40 Controls for in situ PCR analysis included sections where DNA polymerase or primers were omitted and sections from untransfected livers.
Statistical analysis
Results were analyzed using regression analysis and Mann-Whitney U test (SPSS for Windows 6.0).
